跳至主要内容
临床试验/ACTRN12610000319077
ACTRN12610000319077已完成3 期

Social, economic and Health Benefits of Vaccinating Children aged 6 months to 48 months against Influenza. Paediatric Influenza Vaccine Outcome Trial (PIVOT)

Australian Research Council0 个研究点目标入组 600 人开始时间: 2010年4月20日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
6 Months 至 48 Months(—)
性别
All

入选标准

  • Male or female aged greater than or equal to 6 months to <48months at 1st march 2011; who will comply with the requirements of the protocol (e.g. completion of the diaries, return for the follow-up visit). The parent’s/guardian’s ability to understand English is sufficient not to impede the ability to give properly informed consent

排除标准

  • Systemic hypersensitivity to egg proteins, chicken proteins, or any of the vaccine components for the vaccine group. Unstable chronic illness; Known history of Guillain-Barre Syndrome; Plans to enter another clinical trial, or receive an investigational product after receiving vaccine for this trial any time before 31 October 2010; Thrombocytopenia or bleeding disorder and History of psychiatric disorders in the parent/guardian providing consent

研究者

相似试验